Tourmaline Bio
TRML
TRML
56 hedge funds and large institutions have $71M invested in Tourmaline Bio in 2022 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 13 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
45% less capital invested
Capital invested by funds: $129M → $71M (-$58.2M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
56
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$783K | |
| 2 | +$255K | |
| 3 | +$140K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$106K |
| 5 |
Two Sigma Investments
New York
|
+$93K |
Top Sellers
| 1 | -$1.4M | |
| 2 | -$1.34M | |
| 3 | -$1.2M | |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$1.03M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$929K |